Updated:
Stem Cell Network
Stem Cell Network is a not-for-profit organization founded in 2001 in Ottawa, Ontario. It focuses on stem cell and regenerative medicine research within the...
Stem Cell Network
Stem Cell Network is a not-for-profit organization founded in 2001 in Ottawa, Ontario. It focuses on stem cell and regenerative medicine research within the biomedical sector. The organization provides funding, supports clinical trials, and offers training programs.
General information
Firm type
other
Year founded
2001
Location
Region
North America
Country
Canada
City
Ottawa
Corporate office
Ottawa, Ontario, Canada
Principals
Dr. Michael Edel
Scientific Director
Dr. Jennifer MacKenzie
CEO
Sector focus
Frequently asked questions
Who leads the Stem Cell Network?
Dr. Jennifer MacKenzie serves as CEO, and Dr. Michael Edel serves as Scientific Director. Both are based in Ottawa, Canada (per public record).
How does the Stem Cell Network fund research?
The network provides competitive peer-reviewed grants to academic and hospital researchers across Canada. It does not make equity investments or deploy capital on a for-profit basis (per the firm's official communications).
What therapeutic areas does the Stem Cell Network prioritize?
Cardiovascular disease, diabetes, neurodegenerative disorders, and musculoskeletal repair are the main focus areas. The network also supports general regenerative medicine platforms (per public record).
Is the Stem Cell Network a venture capital firm?
No. It is a not-for-profit research consortium funded primarily by federal sources. It does not raise external capital, charge management fees, or take equity positions (per public record).
Where is the Stem Cell Network headquartered?
Ottawa, Ontario, Canada. It does not maintain additional offices (per public record).
Does the Stem Cell Network work with private companies?
Yes, it partners with biotech and pharmaceutical firms to commercialize technologies developed through its funded research. These partnerships typically involve licensing or spinouts (per the firm's official communications).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: